A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection.

Eiki IchiharaKou HasegawaKenichiro KudoYasushi TanimotoKazuhiro NousoNaohiro OdaSho MitsumuneHaruto YamadaIchiro TakataHideharu HagiyaToshiharu MitsuhashiAkihiko TaniguchiShinichi ToyookaKohei TsukaharaToshiyuki AokageHirokazu TsukaharaKatsuyuki KiuraYoshinobu Maeda

Published in: PloS one (2023)

Japan Registry of Clinical Trials jRCTs061200002 (registered on 20/May/2020).

Keyphrases

clinical trial
phase ii
open label
phase iii
study protocol
randomized controlled trial